Xenitra

Xenitra Limited is an Australian-based healthcare and consumer goods company listed on the Australian Securities Exchange (ASX: XEN). The company specializes in the distribution and retail of over-the-counter (OTC) medicines, nutraceuticals, and fast-moving consumer goods (FMCG) through a multichannel ecosystem primarily targeting the Greater China and broader Asian markets. Xenitra operates through B2B wholesale, retail distribution, and major e-commerce platforms, acting as a brand acceleration partner for Western brands entering Asia. Recently, the company has expanded its footprint by acquiring Fukang OTC Pharmacy in Hong Kong and establishing strategic partnerships with groups like Rockcheck for the distribution of Danone products. Additionally, Xenitra is developing the OPAL real-world asset token ecosystem to integrate blockchain-enabled tokenization into its health-related consumer product scaling strategy.